Adam Antebi

Dr. Antebi received his PhD in Biology from Massachusetts Institute of Technology in 1992, and performed his post-doctoral studies at the Johns Hopkins University Baltimore, MD. From 1997 he worked as a Max Planck Independent Group Leader at the Max Planck institute for Molecular Genetics, Berlin, and from 2004 as assistant and then associate professor with Baylor College of Medicine, Houston, Texas. Dr. Antebi is currently one of the founding directors of the newly established Max Planck Institute for Biology of Ageing in Cologne, Germany. He is also an honorary Professor through the University of Cologne, Center of Excellence Cluster on Cellular Stress Response and Age-associated Disease, and continues his affiliation with Baylor College of Medicine at the Huffington Center on Aging. Dr Antebi’s work has focused on endocrine and metabolic regulation of longevity in the small roundworm, Caenorhabditis elegans, an important model system for aging research. Among his findings, he has discovered that components of developmental clocks have been used to regulate animal life span, and discovered that endogenous hexosamine metabolites ameliorate models of neurodegeneration and prolong life. He has worked as an editor in chief of the journal Aging Cell and served on the scientific advisory boards of the Fritz Lipmann Institute (Jena), University of Lyon-NeuroMyoGene Institute, and the Nathan Shock Center, University of Michigan. He has helped establish the Cologne School of Ageing Research, and the Systems Biology of Ageing Network, Cologne. Dr. Antebi is a recipient of the prestigious Ellison Medical Foundation Senior Scholar in Aging Award, the Paul Glenn/American Federation for Aging Research Breakthrough in Gerontology Award, and the Runnstrom Lecture Award.

BACK